A Retrospective Study of Invasive Bacterial Infections in Children with Asplenia.
10.14776/piv.2017.24.3.160
- Author:
Yong Joon CHOE
1
;
Euri SEO
;
Jina LEE
Author Information
1. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, the Republic of Korea. entier@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Splenic diseases;
Vaccination;
Chemoprevention;
Child;
Korea
- MeSH:
Bacteremia;
Bacteria;
Bacterial Infections*;
Chemoprevention;
Child*;
Haemophilus influenzae type b;
Humans;
Immunization;
Incidence;
Korea;
Meningitis;
Neisseria meningitidis;
Retrospective Studies*;
Splenectomy;
Splenic Diseases;
Streptococcus pneumoniae;
Vaccination
- From:Pediatric Infection & Vaccine
2017;24(3):160-167
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Because children with asplenia have an increased risk of fulminant infection associated with a high fatality, chemoprophylaxis, and vaccinations against encapsulated bacteria are recommended. However, there have been few reports of the burden of severe bacterial infection and the current status of chemoprophylaxis and immunization among children with asplenia in Korea. METHODS: We conducted a retrospective study including children with asplenia who were treated at our institute between January 1997 and December 2016. RESULTS: From a total of 213 children with asplenia, 114 (53.5%) had congenital asplenia and 58 (27.2%) had functional asplenia. The remaining 41 (19.3%) had acquired asplenia with the median age at splenectomy being 12.2 years (range, 5.0 to 16.9 years); the most common cause of splenectomy was hereditary spherocytosis (39.0%). The chemoprophylaxis rate was 16.4%. The immunization rates were 44.1% for pneumococcus, 53.0% for Haemophilus influenzae type B, and 10.7% for meningococcus. The incidence of invasive bacterial infection among children with asplenia was 0.28/100 person-year; a total of six episodes (2.8%) were observed in five patients with congenital asplenia and one patient with functional asplenia. The median age for these infections was 15 months (range, 4 to 68 months). Five of the six episodes were bacteremia, and the other was meningitis. The most common pathogen was Streptococcus pneumoniae (n=3), followed by H.influenzae (n=1). Three of the six patients (50.0%) died, all of whom had pneumococcal bacteremia. None of the six had chemoprophylaxis or proper vaccinations. CONCLUSIONS: Although there is an increased risk of a severe infection proper vaccinations and chemoprophylaxis are still lacking. Physicians should be encouraged to implement appropriate chemoprophylaxis and immunizations for patients with asplenia.
